NikaBiotech, a knowledge-based company, was founded in 2020 by a team of highly skilled and motivated experts from prestigious universities across Iran. Currently located in the Ferdowsi University of Mashhad’s Growth Center, the company is dedicated to advancing the livestock and poultry industry through innovation and cutting-edge biotechnology.

NikaBiotech is a pioneer in producing a new generation of advanced feed supplements, and also is active in the development and production of recombinant vaccines for livestock and poultry. By combining innovation with science, we aim to enhance animal health, increase productivity, and reduce the use of antibiotics—ultimately contributing to better quality animal products.

One of our flagship products is CytoGard, an innovative supplement based on postbiotics, which has proven effective and gained significant recognition in the animal health market.

At NikaBiotech, we do not stop at our current successes. We are actively working on several ongoing research and development projects to introduce more innovative solutions, striving to become a leader in the biotechnology industry in Iran.

We believe that knowledge, innovation, and commitment are the three pillars for building a sustainable future in livestock and agriculture.

Success of NikaBiotech in Obtaining Knowledge-Based Certification

In December 2024, NikaBiotech successfully obtained the knowledge-based certification for its innovative product, CytoGard, after passing specialized evaluation procedures conducted by the Knowledge-Based Companies Evaluation Committee. This achievement is the result of the company’s continuous research and development efforts, close collaboration with biotechnology experts, and adherence to global scientific and technical standards.

CytoGard , as an advanced product in the field of feed addetives, relies on cutting-edge technologies and indigenous research to meet critical needs in animal feed science and related industries. Obtaining this certification demonstrates the scientific authenticity and technical innovation of the product, strengthening NikaBiotech's position among the country’s leading companies.

Receiving this license is not only a great honor for NikaBiotech Group, but also a strategic step towards realizing the company's major goals of sustainable development and enhancing Iran's position in the field of biotechnology. With the support of this success, the NikaBiotech team will continue its path to providing innovative and effective products to the country's scientific and industrial community with double motivation.